Pediatric Behcet's disease - clinical aspects and current concepts


Yildiz M., Koker O., Adrovic A., Sahin S., Barut K., KASAPÇOPUR Ö.

EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.7, 2020 (ESCI) identifier identifier

Özet

Behcet's Disease was first described by a Turkish dermatologist, Hulusi Behcet, in 1937 as a triple symptom complex; aphthous stomatitis, genital ulcers, and uveitis. Today, in light of current trials and experiments, we know that the disease may have a wider involvement with a multisystemic recurrent course, causing significant morbidity and mortality. However, there are still unanswered questions, particularly about Pediatric Behcet's Disease. Although several immunological and genetic associations have been demonstrated, the real etiologic mechanism of the disease is unclear. The diagnosis is difficult due to its rarity in childhood, the lack of validation of the diagnostic criteria obtained from adult studies, and the inadequacy of large case-controlled studies. Also, the management is challenging and controversial due to the various geographic distribution of clinical spectrum. New therapeutic options under development in light of pathogenetic hypothesis seem to be promising.